Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway

Molecular Endocrinology

Volumn 26, Issue 8, 2012, Pages 1394-1405

  Lee, Misu ^a   Waser, Beatrice ^b   Reubi, Jean Claude ^b   Pellegata, Natalia S ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P27; SECRETIN; SMALL INTERFERING RNA;

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL STRAIN; CONTROLLED STUDY; ENDOCRINE TUMOR; ENZYME INHIBITION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; AGED; AMINOPYRIDINES; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GASTROINTESTINAL AGENTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMIDAZOLES; MALE; MORPHOLINES; NEURITES; PC12 CELLS; PHEOCHROMOCYTOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; QUINOLINES; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RNA INTERFERENCE; SECRETIN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 84864435955     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1055     Document Type: Article

References (43)

1. Segre GV, Goldring SR 1993 Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-proteinlinked receptor family. Trends Endocrinol Metab 4:309-314
2. Chey WY, Chang TM 2003 Secretin, 100 years later. J Gastroenterol 38:1025-1035
3. Chu JY, Lee LT, Lai CH, Vaudry H, Chan YS, Yung WH, Chow BK 2009 Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci USA 106:15961-15966
4. Davis RJ, Page KJ, Dos Santos Cruz GJ, Harmer DW, Munday PW, Williams SJ, Picot J, Evans TJ, Sheldrick RL, Coleman RA, Clark KL 2004 Expression and functions of the duodenal peptide secretin and its receptor in human lung. Am J Respir Cell Mol Biol 31:302-308
5. Kato A, Gores GJ, LaRusso NF 1992 Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem 267:15523-15529
6. Lenzen R, Alpini G, Tavoloni N 1992 Secretin stimulates bile ductular secretory activity through the cAMP system. Am J Physiol 263:G527-G532
7. Alpini G, Glaser SS, Ueno Y, Pham L, Podila PV, Caligiuri A, LeSage G, LaRusso NF 1998 Heterogeneity of the proliferatie capacity of rat cholangiocytes after bile duct ligation. Am J Physiol 274:G767-G775
8. Das R, Esposito V, Abu-Abed M, Anand GS, Taylor SS, Melacini G 2007 cAMP activation of PKA defines an ancient signaling mechanism. Proc Natl Acad Sci USA 104:93-98
9. Körner M, Hayes GM, Rehmann R, Zimmermann A, Friess H, Miller LJ, Reubi JC 2005 Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Am J Pathol 167:959-968
10. Körner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ, Reubi JC 2006 Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 45:825-835
11. Onori P, Wise C, Gaudio E, Franchitto A, Francis H, Carpino G, Lee V, Lam I, Miller T, Dostal DE, Glaser SS 2010 Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer 127: 43-54
12. Ding WQ, Kuntz S, Böhmig M, Wiedenmann B, Miller LJ 2002 Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. Gastroenterology 122: 500-511
13. Körner MU, Hayes GM, Carrigan PE, Rehmann R, Miller LJ, Reubi JC 2008 Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Mod Pathol 21:387-395
14. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J, Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558-15563
15. Molatore S, Pellegata NS 2010 The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Prog Brain Res 182:295-320
16. Molatore S, Liyanarachchi S, Irmler M, Perren A, Mannelli M, Ercolino T, Beuschlein F, Jarzab B, Wloch J, Ziaja J, Zoubaa S, Neff F, Beckers J, Höfler H, Atkinson MJ, Pellegata NS 2010 Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma. Proc Natl Acad Sci USA 107:18493-18498
17. Virgolini I, Traub T, Novotny C, Leimer M, Fuger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R 2002 Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Design 8:1781-1807
18. Zitzmann K, de Toni E, von Rüden J, Brand S, Göke B, Laubender RP, Auernhammer CJ 2011 The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. Endocr-Relat Cancer 18:277-285
19. Grubman SA, Perrone RD, Lee DW, Murray SL, Rogers LC, Wolkoff LI, Mulberg AE, Cherington V, Jefferson DM 1994 Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 266:G1060-G1070
20. Lichtenauer UD, Shapiro I, Geiger K, Quinkler M, Fassnacht M, Nitschke R, Rückauer KD, Beuschlein F 2008 Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 149:1314-1322
21. Lee M, Theodoropoulou M, Graw J, Roncaroli F, Zatelli MC, Pellegata NS 2011 Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition. Mol Cancer Ther 10:1450-1459
22. Ulrich 2nd CD, Wood P, Hadac EM, Kopras E, Whitcomb DC, Miller LJ 1998 Cellular distribution of secretin receptor expression in rat pancreas. Am J Physiol 275:G1437-G1444
23. Long SH, Berna MJ, Thill M, Pace A, Pradhan TK, Hoffmann KM, Serrano J, Jensen RT 2007 Secretin-receptor and secretin-receptorvariant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results. J Clin Endocrinol Metab 92:4394-4402
24. Ulrich 2nd CD, Holtmann M, Miller LJ 1998 Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114:382-397
25. Ip NY, Baldwin C, Zigmond RE 1985 Regulation of the concenmend.endojournals.org 1405 tration of adenosine 3,5-cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family. J Neurosci 5:1947-1954
26. Kim HS, Yumkham S, Kim SH, Yea K, Shin YC, Ryu SH, Suh PG 2006 Secretin induces neurite outgrowth of PC12 through cAMPmitogen-activated protein kinase pathway. Exp Mol Med 38:85-93
27. Fukuda M, Gotoh Y, Tachibana T, Dell K, Hattori S, Yoneda Y, Nishida E 1995 Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene 11:239-244
28. Takeda S, Okabe S, Funakoshi T, Hirokawa N 1994 Differential dynamics of neurofilament-H protein and neurofilament-L protein in neurons. J Cell Biol 127:173-185
29. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM 2002 PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153-1160
30. Roskoski Jr R, White L, Knowlton R, Roskoski LM 1989 Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Mol Pharmacol 36:925-931
31. Greene LA, Tischler AS 1976 Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428
32. Mahata M, Zhang K, Gayen JR, Nandi S, Brar BK, Ghosh S, Mahapatra NR, Taupenot L, O'Connor DT, Mahata SK 2011 Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin. Cell Tissue Res 345:87-102
33. Mahapatra NR, Mahata M, O'Connor DT, Mahata SK 2003 Secretin activation of chromogranin A gene transcription. Identification of the signaling pathways in cis and in trans. J Biol Chem 278:19986-19994
34. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL 2002 PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8:1145-1152
35. Anderson P, Gonzalez-Rey E 2010 Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels. Mol Cell Biol 30:2537-2551
36. Buteau J, Roduit R, Susini S, Prentki M 1999 Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in (INS-1)-cells. Diabetologia 42:856-864
37. Hui H, Nourparvar A, Zhao X, Perfetti R 2003 Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5-adenosine monophosphate-dependent protein kinase Aand a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444-1455
38. May V, Lutz E, MacKenzie C, Schutz KC, Dozark K, Braas KM 2010 Pituitary adenylate cyclase-activating polypeptide (PACAP)/ PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase and vesicle endocytosis for neuronal survival. J Biol Chem 285:9749-9761
39. Engelman JA 2009 Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9:550-562
40. Guertin DA, Sabatini DM 2007 Defining the role of mTOR in cancer. Cancer Cell 12:9-22
41. Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H 2009 Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells. World J Surg 33:2452-2457
42. Awasthi N, Yen PL, Schwarz MA, Schwarz RE 2012 The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer. J Cell Biochem 113:784-791
43. Leelawat K, Narong S, Udomchaiprasertkul W, Leelawat S, Tungpradubkul S 2009 Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. Cancer Cell Int 9:3